Inactivation of viruses in platelet and plasma products using a riboflavin‐and‐UV–based photochemical treatment

Abstract

The results observed in this study suggest that treating PLT and plasma products with a riboflavin-and-UV-light-based pathogen reduction process could potentially eliminate window period transmission of screened viruses and greatly reduce the risk of transfusion transmission of unscreened viruses.